NO20024355D0 - Nukleosidforbindelser og anvendelser derav - Google Patents

Nukleosidforbindelser og anvendelser derav

Info

Publication number: NO20024355D0
Authority: NO; Norway
Prior art keywords: nucleoside compounds; nucleoside; compounds
Prior art date: 2000-03-15

Application number

NO20024355A

Other languages

English (en)

Other versions

NO20024355L (no

Inventor

Guangyi Wang

Kanda Ramasamy

Lau Johnson

Original Assignee

Icn Pharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-15

Filing date

2002-09-12

Publication date

2002-09-12

2002-09-12 Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals

2002-09-12 Publication of NO20024355D0 publication Critical patent/NO20024355D0/no

2002-11-12 Publication of NO20024355L publication Critical patent/NO20024355L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Transplantation (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

NO20024355A 2000-03-15 2002-09-12 Nukleosidforbindelser og anvendelser derav NO20024355L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US18967200P	2000-03-15	2000-03-15
US09/594,410 US6495677B1 (en)	2000-02-15	2000-06-16	Nucleoside compounds
PCT/US2001/008713 WO2001068663A1 (en)	2000-03-15	2001-03-15	Nucleoside compounds and uses thereof

Publications (2)

Publication Number	Publication Date
NO20024355D0 true NO20024355D0 (no)	2002-09-12
NO20024355L NO20024355L (no)	2002-11-12

Family

ID=26885400

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20024355A NO20024355L (no)	2000-03-15	2002-09-12	Nukleosidforbindelser og anvendelser derav
NO20024385A NO20024385L (no)	2000-03-15	2002-09-13	Antivirale pro-legemidler

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20024385A NO20024385L (no)	2000-03-15	2002-09-13	Antivirale pro-legemidler

Country Status (18)

Country	Link
US (1)	US6495677B1 (no)
EP (2)	EP1207890A4 (no)
JP (2)	JP2003530322A (no)
KR (2)	KR20030062227A (no)
CN (2)	CN1424913A (no)
AU (2)	AU5088101A (no)
BR (2)	BR0109144A (no)
CA (2)	CA2400370A1 (no)
CZ (2)	CZ20023051A3 (no)
DE (1)	DE20121305U1 (no)
HU (2)	HUP0301730A2 (no)
IL (1)	IL151073A0 (no)
MX (2)	MXPA02008608A (no)
NO (2)	NO20024355L (no)
PL (2)	PL365985A1 (no)
RU (2)	RU2002121631A (no)
SK (2)	SK11502002A3 (no)
WO (2)	WO2001068663A1 (no)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7638496B2 (en)	2000-02-15	2009-12-29	Valeant Pharmaceuticals North America	Nucleoside analogs with carboxamidine modified monocyclic base
CN100457118C (zh)	2000-04-13	2009-02-04	法玛塞特有限公司	用于治疗肝炎病毒感染的3′-或2′-羟甲基取代的核苷衍生物
MY164523A (en) *	2000-05-23	2017-12-29	Univ Degli Studi Cagliari	Methods and compositions for treating hepatitis c virus
EA200601591A1 (ru)	2000-05-26	2007-02-27	Айденикс (Кайман) Лимитед	Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
US6815542B2 (en) *	2000-06-16	2004-11-09	Ribapharm, Inc.	Nucleoside compounds and uses thereof
DE10164711A1 (de) *	2001-03-13	2002-10-17	Schebo Biotech Ag	Verwendung von Zuckerphosphaten, Zuckerphosphatanalogen, Aminosäuren und/oder Aminosäureanalogen zur Modulation des Glycolyse-Enzym-Komplexes, des Malat Aspartat Shuttles und/oder der Transaminasen
WO2003026589A2 (en) *	2001-09-28	2003-04-03	Idenix (Cayman) Limited	Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
AU2003213628A1 (en) *	2002-02-28	2003-09-16	Biota, Inc.	Nucleoside 5'-monophosphate mimics and their prodrugs
AU2003229883B2 (en) *	2002-04-03	2009-06-11	Topotarget Uk Limited	Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
NZ537662A (en)	2002-06-28	2007-10-26	Idenix Cayman Ltd	2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7608600B2 (en)	2002-06-28	2009-10-27	Idenix Pharmaceuticals, Inc.	Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
EP1536804A4 (en) *	2002-06-28	2007-10-31	Idenix Cayman Ltd	2'-C-METHYL-3'-O-L-VALINESTER-RIBOFURANOSYLCYTIDINE FOR THE TREATMENT OF FLAVIVIRIDAE INFECTIONS
US8093380B2 (en)	2002-08-01	2012-01-10	Pharmasset, Inc.	Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections
JP2006519753A (ja)	2002-11-15	2006-08-31	イデニクス（ケイマン）リミテツド	２’−分枝ヌクレオシドおよびフラビウイルス科ウイルス突然変異
TWI332507B (en)	2002-11-19	2010-11-01	Hoffmann La Roche	Antiviral nucleoside derivatives
AU2003296601A1 (en) *	2002-12-10	2004-06-30	F. Hoffmann-La Roche Ag	Antiviral nucleoside derivatives
US7598373B2 (en)	2002-12-12	2009-10-06	Idenix Pharmaceuticals, Inc.	Process for the production of 2-C-methyl-D-ribonolactone
NZ540913A (en) *	2002-12-23	2008-02-29	Idenix Cayman Ltd	Process for the production of 3'-nucleoside prodrugs
BRPI0407781A (pt) *	2003-02-25	2006-02-14	Applied Research Systems	aplicação combinada de ribavirina e interferon beta em doenças desmielinizantes
AU2004224575A1 (en) *	2003-03-28	2004-10-07	Pharmasset Ltd.	Compounds for the treatment of flaviviridae infections
EP2345659A1 (en)	2003-05-30	2011-07-20	Pharmasset, Inc.	Modified fluorinated nucleoside analogues
US6930093B2 (en) *	2003-07-10	2005-08-16	Valeant Research & Development	Use of ribofuranose derivatives against inflammatory bowel diseases
CA2533367C (en) *	2003-07-25	2013-10-01	Centre National De La Recherche Scientifique	Purine nucleoside analogues for treating flaviviridae including hepatitis c
WO2005018330A1 (en) *	2003-08-18	2005-03-03	Pharmasset, Inc.	Dosing regimen for flaviviridae therapy
WO2005023827A1 (en) *	2003-09-11	2005-03-17	F. Hoffmann-La Roche Ag	Process for preparing antiviral nucleoside derivatives
CA2537878A1 (en) *	2003-09-11	2005-03-17	F. Hoffmann-La Roche Ag	Polymorphic nucleoside compounds
US20050182252A1 (en)	2004-02-13	2005-08-18	Reddy K. R.	Novel 2'-C-methyl nucleoside derivatives
AU2005254057B2 (en)	2004-06-15	2011-02-17	Isis Pharmaceuticals, Inc.	C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase
EP1912643A2 (en) *	2004-06-23	2008-04-23	Idenix (Cayman) Limited	5-aza-7-deazapurine derivatives for treating infections with flaviviridae
JP5080973B2 (ja)	2004-06-24	2012-11-21	メルク・シャープ・エンド・ドーム・コーポレイション	Ｒｎａ依存性ｒｎａウイルスの感染を処置するためのヌクレオシドアリールホスホルアミダート
CN101023094B (zh)	2004-07-21	2011-05-18	法莫赛特股份有限公司	烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
SG158136A1 (en)	2004-09-14	2010-01-29	Pharmasset Inc	Preparation of 2`-fluoro-2`- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
CN1314702C (zh) *	2004-11-11	2007-05-09	中国人民解放军军事医学科学院放射与辐射医学研究所	核苷类似物胆固醇衍生物
WO2006119061A2 (en)	2005-05-02	2006-11-09	Merck & Co., Inc.	Hcv ns3 protease inhibitors
AR057456A1 (es)	2005-07-20	2007-12-05	Merck & Co Inc	Inhibidores de la proteasa ns3 del vhc
JP4705984B2 (ja)	2005-08-01	2011-06-22	メルク・シャープ・エンド・ドーム・コーポレイション	Ｈｃｖｎｓ３プロテアーゼ阻害剤としての大環状ペプチド
JP5254033B2 (ja)	2005-12-23	2013-08-07	イデニクプハルマセウティカルス，インコーポレイテッド	分岐型ヌクレオシドを調製するための合成中間体の製造方法
GB0609492D0 (en)	2006-05-15	2006-06-21	Angeletti P Ist Richerche Bio	Therapeutic agents
GB0612423D0 (en)	2006-06-23	2006-08-02	Angeletti P Ist Richerche Bio	Therapeutic agents
KR20090094800A (ko) *	2006-09-11	2009-09-08	써던 리서취 인스티튜트	아졸 뉴클레오시드 및 알엔에이와 디엔에이 바이러스성 폴리머라제 억제제로의 이용
US8377873B2 (en)	2006-10-24	2013-02-19	Merck Sharp & Dohme Corp.	HCV NS3 protease inhibitors
US8309540B2 (en)	2006-10-24	2012-11-13	Merck Sharp & Dohme Corp.	HCV NS3 protease inhibitors
EP2079479B1 (en)	2006-10-24	2014-11-26	Merck Sharp & Dohme Corp.	Hcv ns3 protease inhibitors
JP5352464B2 (ja)	2006-10-27	2013-11-27	メルク・シャープ・アンド・ドーム・コーポレーション	Ｈｃｖｎｓ３プロテアーゼ阻害剤
BRPI0718161A2 (pt)	2006-10-27	2013-11-26	Merck & Co Inc	Composto, composição farmacêutica, e, uso do composto.
JP2010513450A (ja)	2006-12-20	2010-04-30	イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー	抗ウイルス性インドール
GB0625345D0 (en)	2006-12-20	2007-01-31	Angeletti P Ist Richerche Bio	Therapeutic compounds
GB0625349D0 (en)	2006-12-20	2007-01-31	Angeletti P Ist Richerche Bio	Therapeutic compounds
CA2673649A1 (en)	2007-01-05	2008-07-17	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
US7964580B2 (en)	2007-03-30	2011-06-21	Pharmasset, Inc.	Nucleoside phosphoramidate prodrugs
AU2008277442A1 (en)	2007-07-17	2009-01-22	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa	Macrocyclic indole derivatives for the treatment of hepatitis C infections
AU2008277377B2 (en)	2007-07-19	2013-08-01	Msd Italia S.R.L.	Macrocyclic compounds as antiviral agents
WO2009036368A2 (en)	2007-09-14	2009-03-19	Nitto Denko Corporation	Drug carriers
US8461107B2 (en)	2008-04-28	2013-06-11	Merck Sharp & Dohme Corp.	HCV NS3 protease inhibitors
US8173621B2 (en)	2008-06-11	2012-05-08	Gilead Pharmasset Llc	Nucleoside cyclicphosphates
KR101313675B1 (ko)	2008-07-22	2013-10-02	이스티투토 디 리세르쉐 디 비올로지아 몰레콜라레 피. 안젤레티 에스.알.엘.	Ｈｃｖｎｓ3 프로테아제 억제제로서의 마크로사이클릭 퀴녹살린 화합물
CN102282155B (zh)	2008-12-02	2017-06-09	日本波涛生命科学公司	磷原子修饰的核酸的合成方法
BRPI0922508A8 (pt)	2008-12-23	2016-01-19	Pharmasset Inc	Análogos de nucleosídeo
KR20110099138A (ko)	2008-12-23	2011-09-06	파마셋 인코포레이티드	뉴클레오시드 포스포르아미데이트
CA2748016A1 (en)	2008-12-23	2010-07-01	Pharmasset, Inc.	Synthesis of purine nucleosides
WO2010082050A1 (en)	2009-01-16	2010-07-22	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
GB0900914D0 (en)	2009-01-20	2009-03-04	Angeletti P Ist Richerche Bio	Antiviral agents
CN102421293A (zh)	2009-03-20	2012-04-18	艾丽奥斯生物制药有限公司	取代的核苷和核苷酸类似物
TWI583692B (zh)	2009-05-20	2017-05-21	基利法瑪席特有限責任公司	核苷磷醯胺
US8618076B2 (en)	2009-05-20	2013-12-31	Gilead Pharmasset Llc	Nucleoside phosphoramidates
KR101885383B1 (ko)	2009-07-06	2018-08-03	웨이브 라이프 사이언시스 리미티드	신규한 핵산 프로드러그 및 그의 사용 방법
WO2011014487A1 (en)	2009-07-30	2011-02-03	Merck Sharp & Dohme Corp.	Hepatitis c virus ns3 protease inhibitors
EP2459211A1 (en)	2009-07-31	2012-06-06	Medtronic, Inc.	Continuous subcutaneous administration of interferon- to hepatitis c infected patients
WO2011076923A1 (en)	2009-12-23	2011-06-30	Institut National De La Sante Et De La Recherche Medicale	Inhibitor for inosine monophosphate (imp) dehydrogenase and/or viral rna polymerase for treatment of hepatitis e
US8563530B2 (en)	2010-03-31	2013-10-22	Gilead Pharmassel LLC	Purine nucleoside phosphoramidate
UY33311A (es)	2010-03-31	2011-10-31	Pharmasset Inc	Fosforamidatos de nucleosidos
MX2013003153A (es)	2010-09-22	2013-05-01	Alios Biopharma Inc	Analogos de nucleotidos sustituidos.
JP5868324B2 (ja)	2010-09-24	2016-02-24	株式会社ＷａｖｅＬｉｆｅＳｃｉｅｎｃｅｓＪａｐａｎ	不斉補助基
ES2716158T3 (es)	2010-11-30	2019-06-10	Gilead Pharmasset Llc	2'-spiro-nucleótidos para el tratamiento de hepatitis C
ES2626488T3 (es)	2011-07-19	2017-07-25	Wave Life Sciences Pte. Ltd.	Procedimientos para la síntesis de ácidos nucleicos funcionalizados
NZ623396A (en)	2011-09-16	2016-07-29	Gilead Pharmasset Llc	Methods for treating hcv
EP2780026B1 (en)	2011-11-15	2019-10-23	Merck Sharp & Dohme Corp.	Hcv ns3 protease inhibitors
US8889159B2 (en)	2011-11-29	2014-11-18	Gilead Pharmasset Llc	Compositions and methods for treating hepatitis C virus
AU2012358804B2 (en)	2011-12-22	2018-04-19	Alios Biopharma, Inc.	Substituted phosphorothioate nucleotide analogs
JP6385825B2 (ja)	2011-12-22	2018-09-05	アリオスバイオファーマインク．	置換されたヌクレオシド、ヌクレオチドおよびそのアナログ
WO2013106344A1 (en)	2012-01-12	2013-07-18	Ligand Pharmaceuticals, Inc.	2 '-c-methyl nucleosides containing a cyclic phosphate diester of 1, 3-propanediol (2-oxo-[1, 3, 2]-dioxaphosphorinane) at position 5'
US9441007B2 (en)	2012-03-21	2016-09-13	Alios Biopharma, Inc.	Substituted nucleosides, nucleotides and analogs thereof
EP2828277A1 (en)	2012-03-21	2015-01-28	Vertex Pharmaceuticals Incorporated	Solid forms of a thiophosphoramidate nucleotide prodrug
USRE48171E1 (en)	2012-03-21	2020-08-25	Janssen Biopharma, Inc.	Substituted nucleosides, nucleotides and analogs thereof
WO2013142157A1 (en)	2012-03-22	2013-09-26	Alios Biopharma, Inc.	Pharmaceutical combinations comprising a thionucleotide analog
PT2861611T (pt)	2012-05-25	2016-10-11	Janssen Sciences Ireland Uc	Nucleósidos de espirooxetano de uracilo
SG11201500239VA (en)	2012-07-13	2015-03-30	Wave Life Sciences Japan	Asymmetric auxiliary group
EP3421482A1 (en)	2012-12-21	2019-01-02	Alios Biopharma, Inc.	Substituted nucleosides, nucleotides and analogs thereof
KR20200060782A (ko)	2013-01-31	2020-06-01	길리애드 파마셋 엘엘씨	두 항바이러스 화합물의 병용 제형물
WO2014121417A1 (en)	2013-02-07	2014-08-14	Merck Sharp & Dohme Corp.	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121418A1 (en)	2013-02-07	2014-08-14	Merck Sharp & Dohme Corp.	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
JP2016529293A (ja)	2013-08-27	2016-09-23	ギリアドファーマセットエルエルシー	２つの抗ウイルス化合物の組合せ製剤
EA201690526A1 (ru)	2013-10-11	2017-02-28	Алиос Биофарма, Инк.	Замещенные нуклеозиды, нуклеотиды и их аналоги
CA2936712A1 (en)	2014-01-16	2015-07-23	Meena	Chiral design
CN114404427A (zh)	2014-02-13	2022-04-29	配体药物公司	前药化合物及其用途
WO2016003812A1 (en)	2014-07-02	2016-01-07	Ligand Pharmaceuticals, Inc.	Prodrug compounds and uses therof
EP3737676B1 (en)	2018-01-09	2024-03-06	Ligand Pharmaceuticals, Inc.	Acetal compounds and therapeutic uses thereof
WO2021138540A1 (en)	2020-01-03	2021-07-08	Berg Llc	Polycyclic amides as ube2k modulators for treating cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3798209A (en)	1971-06-01	1974-03-19	Icn Pharmaceuticals	1,2,4-triazole nucleosides
USRE29835E (en)	1971-06-01	1978-11-14	Icn Pharmaceuticals	1,2,4-Triazole nucleosides
US3991078A (en)	1971-06-01	1976-11-09	Icn Pharmaceuticals, Inc.	N-substituted 1,2,4-triazoles
US3984396A (en)	1971-06-01	1976-10-05	Icn Pharmaceuticals, Inc.	1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US4093624A (en)	1977-01-31	1978-06-06	Icn Pharmaceuticals, Inc.	1,2,4-Thiadiazolidine-3,5-dione
JPS6426593A (en)	1987-07-21	1989-01-27	Asahi Glass Co Ltd	Nucleoside derivative
PL187107B1 (pl)	1996-10-16	2004-05-31	Icn Pharmaceuticals	L-nukleozydy monocykliczne, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie

2000
- 2000-06-16 US US09/594,410 patent/US6495677B1/en not_active Expired - Lifetime
2001
- 2001-03-15 CN CN01806350A patent/CN1424913A/zh active Pending
- 2001-03-15 BR BRPI0109144-1A patent/BR0109144A/pt not_active IP Right Cessation
- 2001-03-15 CZ CZ20023051A patent/CZ20023051A3/cs unknown
- 2001-03-15 HU HU0301730A patent/HUP0301730A2/hu unknown
- 2001-03-15 DE DE20121305U patent/DE20121305U1/de not_active Expired - Lifetime
- 2001-03-15 AU AU50881/01A patent/AU5088101A/en not_active Abandoned
- 2001-03-15 SK SK1150-2002A patent/SK11502002A3/sk unknown
- 2001-03-15 PL PL01365985A patent/PL365985A1/xx unknown
- 2001-03-15 PL PL01366038A patent/PL366038A1/xx unknown
- 2001-03-15 WO PCT/US2001/008713 patent/WO2001068663A1/en not_active Application Discontinuation
- 2001-03-15 CZ CZ20023119A patent/CZ20023119A3/cs unknown
- 2001-03-15 KR KR1020027012033A patent/KR20030062227A/ko not_active Application Discontinuation
- 2001-03-15 SK SK1152-2002A patent/SK11522002A3/sk not_active Application Discontinuation
- 2001-03-15 BR BRPI0109143-3A patent/BR0109143A/pt not_active IP Right Cessation
- 2001-03-15 WO PCT/US2001/008769 patent/WO2001068034A2/en not_active Application Discontinuation
- 2001-03-15 EP EP01924208A patent/EP1207890A4/en not_active Withdrawn
- 2001-03-15 JP JP2001566501A patent/JP2003530322A/ja active Pending
- 2001-03-15 AU AU47556/01A patent/AU4755601A/en not_active Abandoned
- 2001-03-15 EP EP01920509A patent/EP1268504A1/en not_active Withdrawn
- 2001-03-15 CN CN01806351A patent/CN1416431A/zh active Pending
- 2001-03-15 JP JP2001567753A patent/JP2004505889A/ja active Pending
- 2001-03-15 RU RU2002121631/15A patent/RU2002121631A/ru not_active Application Discontinuation
- 2001-03-15 MX MXPA02008608A patent/MXPA02008608A/es unknown
- 2001-03-15 CA CA002400370A patent/CA2400370A1/en not_active Abandoned
- 2001-03-15 RU RU2002121628/04A patent/RU2002121628A/ru not_active Application Discontinuation
- 2001-03-15 HU HU0302334A patent/HUP0302334A2/hu unknown
- 2001-03-15 KR KR1020027012034A patent/KR20030032927A/ko not_active Application Discontinuation
- 2001-03-15 MX MXPA02008609A patent/MXPA02008609A/es unknown
- 2001-03-15 CA CA002400043A patent/CA2400043A1/en not_active Abandoned
2002
- 2002-08-05 IL IL151073A patent/IL151073A0/en unknown
- 2002-09-12 NO NO20024355A patent/NO20024355L/no not_active Application Discontinuation
- 2002-09-13 NO NO20024385A patent/NO20024385L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0301730A2 (hu)	2003-09-29
WO2001068034A3 (en)	2002-03-21
WO2001068034A2 (en)	2001-09-20
BR0109143A (pt)	2006-02-21
HUP0302334A2 (hu)	2003-10-28
WO2001068663B1 (en)	2002-02-14
SK11522002A3 (sk)	2003-04-01
NO20024385D0 (no)	2002-09-13
CN1424913A (zh)	2003-06-18
PL365985A1 (en)	2005-01-24
WO2001068034B1 (en)	2002-05-10
NO20024355L (no)	2002-11-12
BR0109144A (pt)	2006-02-21
EP1268504A1 (en)	2003-01-02
CZ20023119A3 (cs)	2003-05-14
CA2400370A1 (en)	2001-09-20
SK11502002A3 (sk)	2003-03-04
JP2004505889A (ja)	2004-02-26
IL151073A0 (en)	2006-12-31
JP2003530322A (ja)	2003-10-14
RU2002121628A (ru)	2004-02-27
PL366038A1 (en)	2005-01-24
MXPA02008608A (es)	2004-09-06
US6495677B1 (en)	2002-12-17
EP1207890A4 (en)	2003-01-15
KR20030032927A (ko)	2003-04-26
KR20030062227A (ko)	2003-07-23
AU5088101A (en)	2001-09-24
AU4755601A (en)	2001-09-24
CN1416431A (zh)	2003-05-07
EP1207890A2 (en)	2002-05-29
CA2400043A1 (en)	2001-09-20
NO20024385L (no)	2002-11-13
MXPA02008609A (es)	2004-09-06
RU2002121631A (ru)	2004-03-10
WO2001068663A1 (en)	2001-09-20
DE20121305U1 (de)	2002-09-19
CZ20023051A3 (cs)	2003-04-16

Publication	Publication Date	Title
NO20024355D0 (no)	2002-09-12	Nukleosidforbindelser og anvendelser derav
DK1122244T3 (da)	2004-10-25	Uracilforbindelser og anvendelse deraf
DK1417175T3 (da)	2013-10-28	Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
NO20023750D0 (no)	2002-08-08	1H-imidazopyridinderivater
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
ATA2932001A (de)	2004-11-15	Schneefräse
NO20030917D0 (no)	2003-02-27	Anvendelse
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
ATE298751T1 (de)	2005-07-15	7-oxopyridoryrimidine
DK1106607T3 (da)	2005-11-07	Uracilforbindelser og anvendelse deraf
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
NO20013085D0 (no)	2001-06-21	Fosfororganiske forbindelser og deres anvendelse
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
DE50113112D1 (de)	2007-11-22	Schaltungsanordnung
AR027931A1 (es)	2003-04-16	Antitranspirantes
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
DE10052925B4 (de)	2005-03-10	Schaukelbett
DE10085445T1 (de)	2003-02-27	Drahterodierbearbeitungseinrichtung
DE60117096D1 (de)	2006-04-20	Dihydroindol- und tetrahydrochinolinderivate
AR027982A1 (es)	2003-04-23	Aril- y heteroarilsulfonatos
ATE284887T1 (de)	2005-01-15	Thienopyrrolidinone
NO20025135D0 (no)	2002-10-25	Antihypertensive midler og anvendelse

Legal Events

Date	Code	Title	Description
2005-11-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application